2000
DOI: 10.1067/mai.2000.108913
|View full text |Cite
|
Sign up to set email alerts
|

Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
57
2
2

Year Published

2002
2002
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 79 publications
(63 citation statements)
references
References 16 publications
2
57
2
2
Order By: Relevance
“…histamine release assays vs. immunoblotting. Nonetheless, our findings support the concept that positive cutaneous responses to autologous serum characterize a subgroup of patients suffering from ‘autoreactive’ rather than ‘autoimmune’ CU as most ASST+ skin reactions were found to occur in CU patients that did not express Fc ε RI/IgE-targeting autoantibodies [26]. …”
Section: Discussionsupporting
confidence: 65%
“…histamine release assays vs. immunoblotting. Nonetheless, our findings support the concept that positive cutaneous responses to autologous serum characterize a subgroup of patients suffering from ‘autoreactive’ rather than ‘autoimmune’ CU as most ASST+ skin reactions were found to occur in CU patients that did not express Fc ε RI/IgE-targeting autoantibodies [26]. …”
Section: Discussionsupporting
confidence: 65%
“…However, recent work has shown that activation of mast cells or basophils by anti-FcεR1 autoantibodies probably involves complement activation and that the correlation between functional (histamine-releasing) and non-functional (immunoreactive) anti-FcεR1 autoantibodies is poor [52, 53]. Immunoreactive (non-functional) anti-FcεR1 autoantibodies can be found in sera of patients with autoimmune connective tissue diseases, autoimmune bullous diseases and in physical urticarias, but not in healthy individuals.…”
Section: Chronic Idiopathic Urticariamentioning
confidence: 99%
“…For selected experiments, human serum was pretreated as follows. For depletion of gamma globulin, serum aliquots were treated with an equal volume of protein G-coated Sepharose beads (GE Healthcare) as previously described (6). For total inhibition of the complement system, serum was heat inactivated for 30 min at 56°C as described previously (16,28).…”
Section: Antibodiesmentioning
confidence: 99%